AMRUTANJANNSEAmrutanjan Health Care Limited· PharmaceuticalsMediumNeutral
Announced Wed, 24 Sept · 13:46 IST

Submission of revised covering letter along with the proceedings of 88th Annual General Meeting held on Tuesday, 23 September 2025 and request to take the same on record.

Board & Shareholder Meetings View source PDF

AMRUTANJAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Amrutanjan Health Care Limited resubmitted the covering letter for its 88th Annual General Meeting to correct a clerical error: the day of the AGM (September 23, 2025) was wrongly mentioned as Monday instead of Tuesday. The 88th AGM was held on Tuesday, September 23, 2025, at 10:30 AM via video conferencing, chaired by Mr. S. Sambhu Prasad, Chairman & Managing Director, with 84 shareholders participating and 18 registering as speakers. Six ordinary resolutions were put to vote, including approval of audited financial statements for FY ended March 31, 2025, declaration of a final dividend of Rs. 2.60 per equity share of Re. 1 each, appointment of M/s. SPNP & Associates as Secretarial Auditors for five years from FY 2025-26, and approval of Non-Executive Directors' remuneration. The meeting concluded at 11:48 AM, and the e-voting results were to be declared within 48 hours.

Likely market impact

Shareholders gain clarity that a final dividend of Rs. 2.60 per share has been proposed for FY25, and routine governance items (auditor appointments, director remuneration) were approved. The resubmission is purely administrative with no change to substance, so no material impact on the stock is expected.